Probiotics in functional bowel disorders

Best Practice and Research: Clinical Gastroenterology

Volumn 30, Issue 1, 2016, Pages 89-97

  Hod, Keren ^a   Ringel, Yehuda ^b,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Functional bowel disorders; Intestinal mocrobiota; Irritable bowel syndrome; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL PAIN; ARTICLE; BACTERIAL OVERGROWTH; BLOATING; CLINICAL PRACTICE; DIET SUPPLEMENTATION; DRUG USE; FLATULENCE; HUMAN; INTESTINAL SECRETION; INTESTINE FLORA; INTESTINE FUNCTION DISORDER; INTESTINE MOTILITY; META ANALYSIS (TOPIC); MICROBIAL DIVERSITY; MULTICENTER STUDY (TOPIC); NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); GASTROINTESTINAL TRACT; IRRITABLE BOWEL SYNDROME; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; PROBIOTICS;

EID: 84960834601     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2016.01.003     Document Type: Review

References (80)

1. G.F. Longstreth, W.G. Thompson, W.D. Chey, L.A. Houghton, F. Mearin, and R.C. Spiller Functional bowel disorders Gastroenterology 130 5 2006 Apr 1480 1491 PubMed PMID: 16678561
2. Y. Ringel, and D. Drossman Irritable bowel syndrome. Netter's textbook of internal medicine 2nd ed. 2009 419 425
3. Y.A. Saito, P. Schoenfeld, and G.R. Locke 3rd The epidemiology of irritable bowel syndrome in North America: a systematic review Am J Gastroenterol 97 8 2002 Aug 1910 1915 PubMed PMID: 12190153
4. J.Y. Chang, G.R. Locke 3rd, M.A. McNally, S.L. Halder, C.D. Schleck, A.R. Zinsmeister, and et al. Impact of functional gastrointestinal disorders on survival in the community Am J Gastroenterol 105 4 2010 Apr 822 832 PubMed PMID: 20160713. Pubmed Central PMCID: 2887253
5. A.F. Peery, S.D. Crockett, A.S. Barritt, E.S. Dellon, S. Eluri, L.M. Gangarosa, and et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States Gastroenterology 149 7 2015 Dec 1731 1741 e3. PubMed PMID: 26327134. Pubmed Central PMCID: 4663148
6. Y.A. Saito, G.M. Petersen, G.R. Locke 3rd, and N.J. Talley The genetics of irritable bowel syndrome Clin Gastroenterol Hepatol 3 11 2005 Nov 1057 1065 PubMed PMID: 16271334
7. M. Camilleri Peripheral mechanisms in irritable bowel syndrome N Engl J Med 367 17 2012 Oct 25 1626 1635 PubMed PMID: 23094724
8. M. Camilleri Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms J Physiol 592 Pt 14 2014 Jul 15 2967 2980 PubMed PMID: 24665101. Pubmed Central PMCID: 4214653
9. S.R. Gill, M. Pop, R.T. Deboy, P.B. Eckburg, P.J. Turnbaugh, B.S. Samuel, and et al. Metagenomic analysis of the human distal gut microbiome Science 312 5778 2006 Jun 2 1355 1359 PubMed PMID: 16741115. Pubmed Central PMCID: 3027896
10. F. Backhed, C.M. Fraser, Y. Ringel, M.E. Sanders, R.B. Sartor, P.M. Sherman, and et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications Cell Host Microbe 12 5 2012 Nov 15 611 622 PubMed PMID: 23159051
11. J.F. Cryan, and T.G. Dinan Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour Nat Rev Neurosci 13 10 2012 Oct 701 712 PubMed PMID: 22968153
12. J.A. Bravo, M. Julio-Pieper, P. Forsythe, W. Kunze, T.G. Dinan, J. Bienenstock, and et al. Communication between gastrointestinal bacteria and the nervous system Curr Opin Pharmacol 12 6 2012 Dec 667 672 PubMed PMID: 23041079
13. J.R. Kelly, P.J. Kennedy, J.F. Cryan, T.G. Dinan, G. Clarke, and N.P. Hyland Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders Front Cell Neurosci 9 2015 392 PubMed PMID: 26528128. Pubmed Central PMCID: 4604320
14. H.A. Halvorson, C.D. Schlett, and M.S. Riddle Postinfectious irritable bowel syndrome-a meta-analysis Am J Gastroenterol 101 8 2006 Aug 1894 1899 quiz 942. PubMed PMID: 16928253
15. J. Schwille-Kiuntke, P. Enck, C. Zendler, M. Krieg, A.V. Polster, S. Klosterhalfen, and et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter Neurogastroenterol Motil 23 11 2011 Nov e479 e488 PubMed PMID: 21883703
16. P.R. Maxwell, E. Rink, D. Kumar, and M.A. Mendall Antibiotics increase functional abdominal symptoms Am J Gastroenterol 97 1 2002 Jan 104 108 PubMed PMID: 11808932
17. A.C. Ford, B.M. Spiegel, N.J. Talley, and P. Moayyedi Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis Clin Gastroenterol Hepatol 7 12 2009 Dec 1279 1286 PubMed PMID: 19602448
18. D. Yu, F. Cheeseman, and S. Vanner Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS Gut 60 3 2011 Mar 334 340 PubMed PMID: 21112950
19. I. Posserud, P.O. Stotzer, E.S. Bjornsson, H. Abrahamsson, and M. Simren Small intestinal bacterial overgrowth in patients with irritable bowel syndrome Gut 56 6 2007 Jun 802 808 PubMed PMID: 17148502. Pubmed Central PMCID: 1954873
20. M. Rajilic-Stojanovic, D.M. Jonkers, A. Salonen, K. Hanevik, J. Raes, J. Jalanka, and et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 110 2 2015 Feb 278 287 PubMed PMID: 25623659. Pubmed Central PMCID: 4317767
21. Y. Ringel, and I.M. Carroll Alterations in the intestinal microbiota and functional bowel symptoms Gastrointest Endosc Clin N Am 19 1 2009 Jan 141 150 vii. PubMed PMID: 19232285
22. M. Simren, G. Barbara, H.J. Flint, B.M. Spiegel, R.C. Spiller, S. Vanner, and et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report Gut 62 1 2013 Jan 159 176 PubMed PMID: 22730468. Pubmed Central PMCID: 3551212
23. I.M. Carroll, T. Ringel-Kulka, T.O. Keku, Y.H. Chang, C.D. Packey, R.B. Sartor, and et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 301 5 2011 Nov G799 G807 PubMed PMID: 21737778. Pubmed Central PMCID: 3220325
24. I.M. Carroll, T. Ringel-Kulka, J.P. Siddle, and Y. Ringel Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome Neurogastroenterol Motil 24 6 2012 Jun 521 530 e248. PubMed PMID: 22339879. Pubmed Central PMCID: 3975596
25. I.B. Jeffery, P.W. O'Toole, L. Ohman, M.J. Claesson, J. Deane, E.M. Quigley, and et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota Gut 61 7 2012 Jul 997 1006 PubMed PMID: 22180058
26. J. Jalanka-Tuovinen, J. Salojarvi, A. Salonen, O. Immonen, K. Garsed, F.M. Kelly, and et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome Gut 63 11 2014 Nov 1737 1745 PubMed PMID: 24310267
27. M. Rajilic-Stojanovic, E. Biagi, H.G. Heilig, K. Kajander, R.A. Kekkonen, S. Tims, and et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 141 5 2011 Nov 1792 1801 PubMed PMID: 21820992
28. Y. Ringel, and T. Ringel-Kulka The intestinal microbiota and irritable bowel syndrome J Clin Gastroenterol 49 Suppl. 1 2015 Nov-Dec S56 S59 PubMed PMID: 26447966
29. H.M. Staudacher, P.M. Irving, M.C. Lomer, and K. Whelan Mechanisms and efficacy of dietary FODMAP restriction in IBS Nat Rev Gastroenterol Hepatol 11 4 2014 Apr 256 266 PubMed PMID: 24445613
30. H.L. Dupont Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets Aliment Pharmacol Ther 39 10 2014 May 1033 1042 PubMed PMID: 24665829
31. M.H. Floch, W.A. Walker, M.E. Sanders, M. Nieuwdorp, A.S. Kim, D.A. Brenner, and et al. Recommendations for probiotic use-2015 update: proceedings and consensus opinion J Clin Gastroenterol 49 Suppl. 1 2015 Nov-Dec S69 S73 PubMed PMID: 26447969
32. G. Reid, J.A. Younes, H.C. Van der Mei, G.B. Gloor, R. Knight, and H.J. Busscher Microbiota restoration: natural and supplemented recovery of human microbial communities Nat Rev Microbiol 9 1 2011 Jan 27 38 PubMed PMID: 21113182
33. N.V. Varankovich, M.T. Nickerson, and D.R. Korber Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases Front Microbiol 6 2015 685 PubMed PMID: 26236287. Pubmed Central PMCID: 4500982
34. V. Pandey, V. Berwal, N. Solanki, and N.S. Malik Probiotics: healthy bugs and nourishing elements of diet J Int Soc Prev Community Dent 5 2 2015 Mar-Apr 81 87 PubMed PMID: 25992331. Pubmed Central PMCID: 4415334
35. B. Ki Cha, S. Mun Jung, C. Hwan Choi, I.D. Song, H. Woong Lee, H. Joon Kim, and et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial J Clin Gastroenterol 46 3 2012 Mar 220 227 PubMed PMID: 22157240
36. W. Kruis, S. Chrubasik, S. Boehm, C. Stange, and J. Schulze A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome Int J Colorectal Dis 27 4 2012 Apr 467 474 PubMed PMID: 22130826. Pubmed Central PMCID: 3307993
37. G. Pineton de Chambrun, C. Neut, A. Chau, M. Cazaubiel, F. Pelerin, P. Justen, and et al. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome Dig Liver Dis 47 2 2015 Feb 119 124 PubMed PMID: 25488056
38. G. Sisson, S. Ayis, R.A. Sherwood, and I. Bjarnason Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome-a 12 week double-blind study Aliment Pharmacol Ther 40 1 2014 Jul 51 62 PubMed PMID: 24815298
39. J.S. Yoon, W. Sohn, O.Y. Lee, S.P. Lee, K.N. Lee, D.W. Jun, and et al. Effect of multi-species probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial J Gastroenterol Hepatol 29 1 2013 Jul 5 52 59
40. H. Yoon, Y.S. Park, D.H. Lee, J.G. Seo, C.M. Shin, and N. Kim Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial J Clin Biochem Nutr 57 2 2015 Sep 129 134 PubMed PMID: 26388670. Pubmed Central PMCID: 4566021
41. J.S. Yoon, W. Sohn, O.Y. Lee, S.P. Lee, K.N. Lee, D.W. Jun, and et al. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial J Gastroenterol Hepatol 29 1 2014 Jan 52 59 PubMed PMID: 23829297
42. P. Ducrotte, P. Sawant, and V. Jayanthi Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome World J Gastroenterol 18 30 2012 Aug 14 4012 4018 PubMed PMID: 22912552. Pubmed Central PMCID: 3419998
43. A. Gawronska, P. Dziechciarz, A. Horvath, and H. Szajewska A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children Aliment Pharmacol Ther 25 2 2007 Jan 15 177 184 PubMed PMID: 17229242
44. R. Francavilla, V. Miniello, A.M. Magista, A. De Canio, N. Bucci, F. Gagliardi, and et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain Pediatrics 126 6 2010 Dec e1445 e1452 PubMed PMID: 21078735
45. M. Bauserman, and S. Michail The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial J Pediatr 147 2 2005 Aug 197 201 PubMed PMID: 16126049
46. C. Koebnick, I. Wagner, P. Leitzmann, U. Stern, and H.J. Zunft Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation Can J Gastroenterol 17 11 2003 Nov 655 659 PubMed PMID: 14631461
47. D.L. Waitzberg, L.C. Logullo, A.F. Bittencourt, R.S. Torrinhas, G.M. Shiroma, N.P. Paulino, and et al. Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response Clin Nutr 32 1 2013 Feb 27 33 PubMed PMID: 22959620
48. Y.X. Yang, M. He, G. Hu, J. Wei, P. Pages, X.H. Yang, and et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women World J Gastroenterol 14 40 2008 Oct 28 6237 6243 PubMed PMID: 18985817. Pubmed Central PMCID: 2761588
49. S.E. Kim, S.C. Choi, K.S. Park, M.I. Park, J.E. Shin, T.H. Lee, and et al. Change of fecal Flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation J Neurogastroenterol Motil 21 1 2015 Jan 1 111 120 PubMed PMID: 25537674. Pubmed Central PMCID: 4288088
50. M.M. Mazlyn, L.H. Nagarajah, A. Fatimah, A.K. Norimah, and K.L. Goh Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study J Gastroenterol Hepatol 28 7 2013 Jul 1141 1147 PubMed PMID: 23432408
51. Hilli L. L SK, J. Orlowski, J.L. Kupperman, M. Baral, and R FW Efficacy of probiotics and nutrients in functional gastrointestinal disorders: a preliminary clinical trial Dig Dis Sci 51 12 2006 Dec 2134 2144 PubMed PMID: 17078006
52. P.A. Waller, P.K. Gopal, G.J. Leyer, A.C. Ouwehand, C. Reifer, M.E. Stewart, and et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults Scand J Gastroenterol 46 9 2011 Sep 1057 1064 PubMed PMID: 21663486. Pubmed Central PMCID: 3171707
53. T. Ringel-Kulka, O.S. Palsson, D. Maier, I. Carroll, J.A. Galanko, G. Leyer, and et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study J Clin Gastroenterol 45 6 2011 Jul 518 525 PubMed PMID: 21436726
54. D.S. Kalman, H.I. Schwartz, P. Alvarez, S. Feldman, J.C. Pezzullo, and D.R. Krieger A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms BMC Gastroenterol 9 2009 85 PubMed PMID: 19922649. Pubmed Central PMCID: 2784472
55. Design of Treatment Trials C, E.J. Irvine, W.E. Whitehead, W.D. Chey, K. Matsueda, M. Shaw, and et al. Design of treatment trials for functional gastrointestinal disorders Gastroenterology 130 5 2006 Apr 1538 1551 PubMed PMID: 16678567
56. M. Ortiz-Lucas, A. Tobias, P. Saz, and J.J. Sebastian Effect of probiotic species on irritable bowel syndrome symptoms: a bring up to date meta-analysis Rev Esp Enferm Dig 105 1 2013 Jan 19 36 PubMed PMID: 23548007
57. B. Tiequn, C. Guanqun, and Z. Shuo Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis Intern Med 54 3 2015 243 249 PubMed PMID: 25748731
58. L.V. McFarland, and S. Dublin Meta-analysis of probiotics for the treatment of irritable bowel syndrome World J Gastroenterol 14 17 2008 May 7 2650 2661 PubMed PMID: 18461650
59. N. Hoveyda, C. Heneghan, K.R. Mahtani, R. Perera, N. Roberts, and P. Glasziou A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome BMC Gastroenterol 9 2009 15 PubMed PMID: 19220890
60. T. Didari, S. Mozaffari, S. Nikfar, and M. Abdollahi Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis World J Gastroenterol 21 10 2015 Mar 14 3072 3084 PubMed PMID: 25780308. Pubmed Central PMCID: 4356930
61. A.P. Hungin, C. Mulligan, B. Pot, P. Whorwell, L. Agreus, P. Fracasso, and et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide Aliment Pharmacol Ther 38 8 2013 Oct 864 886 PubMed PMID: 23981066. Pubmed Central PMCID: 3925990
62. A.C. Ford, E.M. Quigley, B.E. Lacy, A.J. Lembo, Y.A. Saito, L.R. Schiller, and et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis Am J Gastroenterol 109 10 2014 Oct 1547 1561 quiz 6, 62. PubMed PMID: 25070051
63. A. Chmielewska, and H. Szajewska Systematic review of randomised controlled trials: probiotics for functional constipation World J Gastroenterol 16 1 2010 Jan 7 69 75 PubMed PMID: 20039451. Pubmed Central PMCID: 2799919
64. E. Dimidi, S. Christodoulides, K.C. Fragkos, S.M. Scott, and K. Whelan The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials Am J Clin Nutr 100 4 2014 Oct 1075 1084 PubMed PMID: 25099542
65. L.E. Miller Study design considerations for irritable bowel syndrome clinical trials Ann Gastroenterol 27 4 2014 338 345 quarterly publication of the Hellenic Society of Gastroenterology, PubMed PMID: 25330749. Pubmed Central PMCID: 4188930
66. M. Corsetti, and J. Tack FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome? Neurogastroenterol Motil 25 6 2013 Jun 453 457 PubMed PMID: 23672677
67. L. O'Mahony, J. McCarthy, P. Kelly, G. Hurley, F. Luo, K. Chen, and et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles Gastroenterology 128 3 2005 Mar 541 551 PubMed PMID: 15765388
68. P.J. Whorwell, L. Altringer, J. Morel, Y. Bond, D. Charbonneau, L. O'Mahony, and et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome Am J Gastroenterol 101 7 2006 Jul 1581 1590 PubMed PMID: 16863564
69. K. Kajander, K. Hatakka, T. Poussa, M. Farkkila, and R. Korpela A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention Aliment Pharmacol Ther 22 5 2005 Sep 1 387 394 PubMed PMID: 16128676
70. K. Kajander, E. Myllyluoma, M. Rajilic-Stojanovic, S. Kyronpalo, M. Rasmussen, S. Jarvenpaa, and et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota Aliment Pharmacol Ther 27 1 2008 Jan 1 48 57 PubMed PMID: 17919270
71. H.J. Kim, M.I. Vazquez Roque, M. Camilleri, D. Stephens, D.D. Burton, K. Baxter, and et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating Neurogastroenterol Motil 17 5 2005 Oct 687 696 PubMed PMID: 16185307
72. S. Guandalini, G. Magazzu, A. Chiaro, V. La Balestra, G. Di Nardo, S. Gopalan, and et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study J Pediatr Gastroenterol Nutr 51 1 2010 Jul 24 30 PubMed PMID: 20453678
73. S. Michail, and H. Kenche Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant irritable bowel syndrome Probiotics Antimicrob Proteins 3 1 2011 Mar 1 7 PubMed PMID: 22247743. Pubmed Central PMCID: 3255476
74. H.J. Kim, M. Camilleri, S. McKinzie, M.B. Lempke, D.D. Burton, G.M. Thomforde, and et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 17 7 2003 Apr 1 895 904 PubMed PMID: 12656692
75. A. Agrawal, L.A. Houghton, J. Morris, B. Reilly, D. Guyonnet, N. Goupil Feuillerat, and et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation Aliment Pharmacol Ther 29 1 2009 Jan 104 114 PubMed PMID: 18801055
76. D. Guyonnet, O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C.H. Mercier, and et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial Aliment Pharmacol Ther 26 3 2007 Aug 1 475 486 PubMed PMID: 17635382
77. L.M. Roberts, D. McCahon, R. Holder, S. Wilson, and F.D. Hobbs A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome BMC Gastroenterol 13 2013 45 PubMed PMID: 23496803. Pubmed Central PMCID: 3605320
78. J. Zeng, Y.Q. Li, X.L. Zuo, Y.B. Zhen, J. Yang, and C.H. Liu Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 28 8 2008 Oct 15 994 1002 PubMed PMID: 18671775
79. T. Sakai, H. Makino, E. Ishikawa, K. Oishi, and A. Kushiro Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population Int J Food Sci Nutr 62 4 2011 Jun 423 430 PubMed PMID: 21322768
80. P. Moayyedi, A.C. Ford, N.J. Talley, F. Cremonini, A.E. Foxx-Orenstein, L.J. Brandt, and et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review Gut 59 3 2010 Mar 325 332 PubMed PMID: 19091823